Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the approval of ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), as a new first-line maintenance ...
As PCMag's resident data journalist, I practically live in Microsoft Excel. I've learned that it's capable of far more than I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results